---
category: news
title: "BioXcel Therapeutics Provides Update on its BXCL501 Program for the Acute Treatment of Dementia ..."
excerpt: "Company initiated supplemental 40 mcg dose cohort to help inform clinical development strategy across the full range of dementia care settings End of Phase 2 meeting scheduled with U.S. Food and Drug Administration (“FDA”) in Q2 2021 NEW HAVEN,"
publishedDateTime: 2021-03-03T04:02:00Z
originalUrl: "https://apnews.com/press-release/globenewswire-mobile/business-technology-products-and-services-government-regulations-drug-approvals-4bf1e25a5361d2d0c25f89a86eeff99b"
webUrl: "https://apnews.com/press-release/globenewswire-mobile/business-technology-products-and-services-government-regulations-drug-approvals-4bf1e25a5361d2d0c25f89a86eeff99b"
type: article
quality: 10
heat: 10
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "G50J9T8h+Pj6LAoubb6+lhMfeqgasw4zP5pxU2D+2N6+5CSuGGTHmSSmwl17+NrKdFE0S2n30pd5CSWQWhvxwt+dM5Qn9n4auWvIEe5e2WlRYNgcGq55Zj/L28vj2XGTvlV1Lq0N1+fzR8tJeaEEgDGS1er27+UW09nQFQhD5H4B7dIhkZ2sOGoehx+lhb/VXX9/pnXgTz/Y5CcDM4QpZv6QY6nSHmLm5fozga1ap9JCXZ3Qr06i/alS/acBdUUGe93ob7KFRi/0s3w+wWxvcuje9bqjWtHh63um3CrzAU0bTnisOSAGyv7jURUjxMEy0W7ZDXA1CycRKJVLwLZeaSrHg1tBTgNWshCX+cBhzXw=;iQVIem1o/vxZXLzvit9XIA=="
---

